Junel Fe 24

Pregnancy Prevention

Junel Fe 24 is indicated for use by females of reproductive potential to prevent pregnancy. It is a combination oral contraceptive that contains two types of hormones: an estrogen (ethinyl estradiol) and a progestin (norethindrone acetate).

This medication works to prevent pregnancy through several different methods:

• It inhibits ovulation, which is the release of an egg from the ovaries.
• It thickens the mucus in the cervix, which makes it more difficult for sperm to travel to the egg.
• It changes the lining of the uterus, making it less likely that a fertilized egg will be able to attach and grow.

Daily Routine and Iron

The medication is provided in a 28-day cycle pack. The first 24 tablets contain the active hormones. The final 4 tablets are reminder pills that contain ferrous fumarate (iron). These iron-containing pills are included to help you stay in the habit of taking one pill every day at the same time. While they provide a small amount of iron, they are not intended to treat iron deficiency or anemia.

Primary Mechanism

Junel Fe 24 works mainly by preventing ovulation, which is the monthly release of an egg from the ovaries. It uses two hormones, a progestin (norethindrone acetate) and an estrogen (ethinyl estradiol), to signal the body to suppress the hormones normally responsible for triggering ovulation.

Secondary Effects

In addition to stopping ovulation, this medication helps prevent pregnancy through other physical changes:

• Cervical Mucus: It thickens the mucus at the opening of the uterus (cervix). This makes it more difficult for sperm to travel into the uterus to reach an egg.
• Uterine Lining: It alters the lining of the uterus (endometrium). These changes make it less likely for a fertilized egg to attach to the uterine wall.

The Role of Iron Tablets

The pack includes four brown tablets containing ferrous fumarate (iron). These tablets do not contain hormones and do not contribute to pregnancy prevention. They are included to help users maintain a daily habit of taking a pill and to provide a small amount of iron during the days when withdrawal bleeding typically occurs.

Common Side Effects

Many users experience mild side effects, particularly during the first few months of treatment. These may include:

• Nausea and vomiting
• Stomach cramps or bloating
• Headache or migraine
• Breast tenderness or enlargement
• Weight changes
• Spotting or breakthrough bleeding between periods
• Missed menstrual periods
• Vaginal yeast infections
• Mood swings or depression
• Acne

Serious Side Effects

Seek emergency medical help if you have signs of an allergic reaction, such as hives, difficulty breathing, or swelling of the face and throat. Contact your doctor immediately if you experience:

• Signs of a blood clot: Sudden numbness or weakness, severe headache, problems with vision or speech, pain or swelling in one leg, or shortness of breath.
• Liver problems: Upper stomach pain, tiredness, dark urine, or yellowing of the skin and eyes.
• Heart issues: Chest pain or pressure, or pain spreading to the jaw or shoulder.
• Gallbladder issues: Severe pain in the upper abdomen or loss of appetite.
• Mental health changes: New or worsening depression or sleep problems.
• Blood pressure changes: Severe headache, blurred vision, or pounding in your neck or ears.

The brown tablets in the pack contain iron (ferrous fumarate), which is not for therapeutic use but may cause minor gastrointestinal symptoms in some individuals.

Cigarette Smoking and Cardiovascular Risk

Cigarette smoking increases the risk of serious cardiovascular side effects from combination oral contraceptive use. This risk increases with age and with heavy smoking (15 or more cigarettes per day) and is quite marked in women over 35 years of age. Women who use combination oral contraceptives are strongly advised not to smoke.

Blood Clots and Stroke

The use of Junel Fe 24 is associated with an increased risk of several serious conditions, including:

• Blood clots in the legs (deep vein thrombosis) or lungs (pulmonary embolism).
• Stroke or heart attack.
• Blockages in the blood vessels of the eyes.

The risk of blood clots is highest during the first year of use or when restarting hormonal birth control after a break of four weeks or longer.

Liver Problems

This medication should be discontinued if jaundice (yellowing of the skin or eyes) develops. It can also cause rare, non-cancerous or cancerous liver tumors, which may lead to life-threatening internal bleeding. People with active liver disease or certain liver tumors should not use this medication.

Cancer Risks

Junel Fe 24 should not be used by individuals who have or have had breast cancer or other cancers sensitive to hormones, as these hormones may encourage tumor growth.

Other Precautions

• High Blood Pressure: This medication can cause an increase in blood pressure. Blood pressure should be monitored regularly.
• Gallbladder Disease: There is an increased risk of gallbladder disease in users of combination oral contraceptives.
• Diabetes and Cholesterol: This medication may affect blood sugar levels and lipid levels in the blood. People with diabetes or high cholesterol should be monitored closely.
• Headaches: The onset or worsening of migraines or the development of a new pattern of headaches requires evaluation.

When Not to Use Junel Fe 24

This medication is generally not recommended for individuals with:

• A history of blood clots, heart attack, or stroke.
• Chest pain (angina pectoris).
• Known or suspected pregnancy.
• Unexplained vaginal bleeding.
• Severe high blood pressure.
• Diabetes with blood vessel damage.
• Certain types of migraines with aura.

Pregnancy

Junel Fe 24 is a birth control medication and should not be taken by individuals who are already pregnant. If you become pregnant or suspect you are pregnant while taking this medication, you should stop taking it and consult a healthcare provider. Research into the accidental use of oral contraceptives during early pregnancy has generally shown no increased risk of birth defects or adverse effects on the developing fetus.

Breastfeeding

The use of combined oral contraceptives like Junel Fe 24 while breastfeeding is generally not recommended until the infant has been weaned. Potential considerations include:

• Milk Supply: The hormones in this medication can decrease the amount of breast milk produced and may change its nutritional composition.
• Hormone Transfer: Small amounts of the active hormones are excreted into breast milk. While adverse effects on nursing infants are rarely reported, the long-term impact is not fully known.

Healthcare providers typically suggest using non-hormonal forms of contraception while breastfeeding. Discuss your options with a clinician to determine the safest timing for starting or resuming hormonal birth control.

Available Forms

Junel Fe 24 is supplied as a tablet for oral administration. It is provided in a blister dispenser designed for a monthly cycle.

Tablet Types

• Active Tablets: These tablets contain the hormonal ingredients used to prevent pregnancy.
• Reminder Tablets: These tablets contain ferrous fumarate and do not contain hormones. They are intended to help the user maintain a daily dosing habit during the final days of the cycle.

FDA Approval and Indication

Junel Fe 24 is approved by the U.S. Food and Drug Administration (FDA) for the prevention of pregnancy in women who choose to use oral contraceptives as a method of birth control. It is a combination hormonal pill containing a progestin (norethindrone acetate) and an estrogen (ethinyl estradiol).

Boxed Warning

The FDA-approved labeling for Junel Fe 24 includes a boxed warning concerning cigarette smoking and serious cardiovascular events. Important safety information includes:

• Cigarette smoking increases the risk of serious cardiovascular side effects from combination oral contraceptive use.
• This risk increases with age and with the number of cigarettes smoked.
• The risk is most significant in women over 35 years of age.
• Women who are over 35 years old and smoke should not use this medication.

Regulatory Status and Requirements

Junel Fe 24 is available only by prescription. It is supplied in a 28-day regimen consisting of 24 active tablets and 4 reminder tablets containing ferrous fumarate (iron). The iron tablets are included to help maintain the daily dosing habit and do not serve a therapeutic purpose for iron deficiency. There are no specific Risk Evaluation and Mitigation Strategies (REMS) required for this drug beyond the standard physician labeling and patient package insert.

Weight Changes and Junel Fe 24

Weight change is a documented side effect associated with the use of Junel Fe 24. Clinical data indicates that users may experience either an increase or a decrease in weight while taking this medication.

Potential Factors

Several factors may contribute to weight changes while using hormonal contraceptives:

• Fluid Retention: The hormones in Junel Fe 24 can cause the body to retain sodium and water, which may lead to bloating or a slight increase in weight, particularly when first starting the medication.
• Appetite Fluctuations: Some users report changes in appetite, which can influence caloric intake and body weight over time.

While many people concern themselves with weight gain when starting birth control, significant weight gain is not a guaranteed side effect for everyone. If you experience rapid or concerning weight changes, consult a healthcare professional to evaluate your symptoms and discuss whether this medication is appropriate for you.